Consider patients' disease states, medication regimens, and other regularly used nonprescription drugs.
To maximize this challenging experience, pharmacy students should be eager to learn and inquisitive.
Health care policy decisions based on sound data and research are essential for addressing the challenges.
Although specialty therapies have the potential to help people live healthier lives, their cost and complexity can create distinct challenges.
With so many radical developments in medicine and technology unfolding at once, the role and potential of the pharmacy as we know it is evolving at breakneck speed.
Opportunities for further optimization of CML management remain.
There is a real opportunity for technology to alleviate some of the administrative burdens pharmacists face so that they have more time to focus on patient care.
Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.
Prescription labels have a lot of details on them, which can make it difficult for patients to find and use important information.
Use of these drugs as medications, though, promising, may be restricted for various reasons to a select few.
Mobile apps can help consumers acquire medications, but few help with adherence beyond automatic refills or medication synchronization.
These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.
Axitinib, cabozantinib, and lenvatinib are first-line treatment options.
Pharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.
Specific drugs, foods, and supplements can lead to this condition.
Experts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.
Mitigating the likelihood of pharmacy staff burnout requires a multifactorial approach.
Combination netupitant and palonosetron capsules/fosnetupitant and palonosetron for injection (Akynzeo) is indicated to prevent acute and delayed nausea and vomiting associated with highly emetogenic chemotherapy.
Pharmacy professionals can bring in the right people at the right time to identify needed changes and develop an action plan.
Finding ways to eliminate barriers to care helps narrow the gap.
In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.
Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.
Immunotherapies will continue to change standards of care for treatment of RCC.
Prior authorizations have delayed time to treatment for patients and can directly impact clinical outcomes.
Protecting this vulnerable patient population requires specially designed strategies.
Pharmacists must remain nimble to help patients continue receiving the medications they need, as technology now plays a central role in workflow and medication management.
Clinical pharmacy services became eligible for reimbursement by all health insurance in Germany; however, challenges persist in upscaling and sustaining these services.
Sixty years after the first hormonal birth control pill was marketed to women, men still have limited options with variable efficacy for birth control.